Citadel Advisors’s Immutep IMMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-800
Closed -$5.62K – 14246
2026
Q1
$5.62K Buy
+800
New +$36.6K ﹤0.01% 12809
2025
Q4
– Sell
-550
Closed -$19.2K – 13321
2025
Q3
$19.2K Sell
550
-815
-60% -$27.7K ﹤0.01% 12495
2025
Q2
$44.8K Buy
1,365
+185
+16% +$6.45K ﹤0.01% 11827
2025
Q1
$41.5K Sell
1,180
-45
-4% -$1.73K ﹤0.01% 12508
2024
Q4
$53.2K Buy
1,225
+90
+8% +$3.62K ﹤0.01% 12329
2024
Q3
$50.2K Sell
1,135
-85
-7% -$3.75K ﹤0.01% 11916
2024
Q2
$49K Buy
1,220
+645
+112% +$34.6K ﹤0.01% 11780
2024
Q1
$26.8K Sell
575
-80
-12% -$3.79K ﹤0.01% 12790
2023
Q4
$31.4K Sell
655
-165
-20% -$6.52K ﹤0.01% 12229
2023
Q3
$31.2K Sell
820
-710
-46% -$28.8K ﹤0.01% 12242
2023
Q2
$64.6K Buy
1,530
+695
+83% +$26K ﹤0.01% 11500
2023
Q1
$28.1K Buy
835
+345
+70% +$12.7K ﹤0.01% 12796
2022
Q4
$17.2K Sell
490
-280
-36% -$11.1K ﹤0.01% 13260
2022
Q3
$24K Sell
770
-215
-22% -$8.74K ﹤0.01% 12002
2022
Q2
$40K Sell
985
-380
-28% -$18.8K ﹤0.01% 12063
2022
Q1
$75K Buy
1,365
+135
+11% +$7.65K ﹤0.01% 12521
2021
Q4
$81K Buy
+1,230
New +$93.9K ﹤0.01% 12931
2021
Q3
– Sell
-1,385
Closed -$107K – 14206
2021
Q2
$107K Buy
+1,385
New +$110K ﹤0.01% 12863

Other funds holding IMMP

Citadel Advisors's IMMP Position: Q2 2026 in Review

Citadel Advisors sold out of Immutep (IMMP) in Q2 2026, closing a stake of 3,909 shares — an estimated $34K sold.

Citadel Advisors first reported a position in IMMP in Q4 2013 and held it in 28 quarters. The position peaked at $220K in Q3 2021. 24 funds tracked by Wall St. Rank hold IMMP as of Q2 2026.

  • Citadel Advisors reported no remaining Immutep position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 3,909 Immutep shares in Q2 2026, an estimated $34K.
  • Citadel Advisors first reported a position in Immutep in Q4 2013 and held it in 28 quarters.
  • Citadel Advisors's Immutep position peaked at $220K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Immutep as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.